Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis

Tong You Wade Wei, Jiun Yi Hsia, Shao Chih Chiu, Li Jen Su, Chi Chang Juan, Yuan Chii Gladys Lee, Jo Mei Maureen Chen, Hsiang Yun Chou, Jiao Ying Huang, Hiang Ming Huang, Chang Tze Ricky Yu

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Methylosome protein 50 (MEP50) is a component of methylosome where MEP50 binds protein substrates and activates the oncogenic protein arginine methyl transferase 5 (PRMT5). MEP50 is also a coactivator for androgen receptor (AR) and estrogen receptor (ER), and transforms cells in the presence of androgen or estrogen. To extend the understanding of how MEP50 transforms cells, we investigated whether MEP50 could transform cells independent of AR and ER, and clarified whether PRMT5 could contribute to the MEP50-caused tumor formation. Microarray and Western blot analyses revealed the association of MEP50 with many human cancers including lung cancer. Knockdown of MEP50 retarded cell growth and migration in selected lung cancer cell lines, which expressed very low level of AR and ER and were insensitive to inhibitors of AR and ER. Moreover, overexpression of Myc-MEP50 enhanced cell transforming activities of 293T cells which are known lack of expression of AR and ER. Mechanistic analyses showed that MEP50 controlled G2 progression, upregulated cyclin-dependent kinase 1(CDK1)/cyclin B1, and activated the survival cascade Phosphoinositide 3-kinase (PI3K)/AKT. MEP50 promoted cell migration, and activated the cell migration pathways such as Ras-related C3 botulinum toxin substrate 1 (Rac1)/vasodilator-stimulated phosphoprotein (VASP), and forkhead box protein A2 (FOXA2)/slug/cadherin cascades. Further analyses revealed that MEP50 activated the survival factor PI3K through PRMT5-catalyzed dimethylation of PI3K. Collectively, it is concluded that MEP50 can transform cells independent of AR and ER, and PRMT5 has partial contribution to that process.

Original languageEnglish
Pages (from-to)2940-2950
Number of pages11
JournalCellular Signalling
Volume26
Issue number12
DOIs
Publication statusPublished - Sep 1 2014

Fingerprint

Androgens
Estrogens
Carcinogenesis
Proteins
Androgen Receptors
Estrogen Receptors
Transferases
1-Phosphatidylinositol 4-Kinase
Arginine
Cell Movement
Lung Neoplasms
Hepatocyte Nuclear Factor 3-beta
rac1 GTP-Binding Protein
CDC2 Protein Kinase
Cyclin B1
Gastropoda
Survival
HEK293 Cells
Cadherins

Keywords

  • AKT
  • Androgen
  • Estrogen
  • MEP50
  • PI3K
  • PRMT5

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)

Cite this

Wei, T. Y. W., Hsia, J. Y., Chiu, S. C., Su, L. J., Juan, C. C., Lee, Y. C. G., ... Yu, C. T. R. (2014). Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis. Cellular Signalling, 26(12), 2940-2950. https://doi.org/10.1016/j.cellsig.2014.09.014

Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis. / Wei, Tong You Wade; Hsia, Jiun Yi; Chiu, Shao Chih; Su, Li Jen; Juan, Chi Chang; Lee, Yuan Chii Gladys; Chen, Jo Mei Maureen; Chou, Hsiang Yun; Huang, Jiao Ying; Huang, Hiang Ming; Yu, Chang Tze Ricky.

In: Cellular Signalling, Vol. 26, No. 12, 01.09.2014, p. 2940-2950.

Research output: Contribution to journalArticle

Wei, TYW, Hsia, JY, Chiu, SC, Su, LJ, Juan, CC, Lee, YCG, Chen, JMM, Chou, HY, Huang, JY, Huang, HM & Yu, CTR 2014, 'Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis', Cellular Signalling, vol. 26, no. 12, pp. 2940-2950. https://doi.org/10.1016/j.cellsig.2014.09.014
Wei, Tong You Wade ; Hsia, Jiun Yi ; Chiu, Shao Chih ; Su, Li Jen ; Juan, Chi Chang ; Lee, Yuan Chii Gladys ; Chen, Jo Mei Maureen ; Chou, Hsiang Yun ; Huang, Jiao Ying ; Huang, Hiang Ming ; Yu, Chang Tze Ricky. / Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis. In: Cellular Signalling. 2014 ; Vol. 26, No. 12. pp. 2940-2950.
@article{d688d8c6fb0c433e9e6d748a8e982bc4,
title = "Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis",
abstract = "Methylosome protein 50 (MEP50) is a component of methylosome where MEP50 binds protein substrates and activates the oncogenic protein arginine methyl transferase 5 (PRMT5). MEP50 is also a coactivator for androgen receptor (AR) and estrogen receptor (ER), and transforms cells in the presence of androgen or estrogen. To extend the understanding of how MEP50 transforms cells, we investigated whether MEP50 could transform cells independent of AR and ER, and clarified whether PRMT5 could contribute to the MEP50-caused tumor formation. Microarray and Western blot analyses revealed the association of MEP50 with many human cancers including lung cancer. Knockdown of MEP50 retarded cell growth and migration in selected lung cancer cell lines, which expressed very low level of AR and ER and were insensitive to inhibitors of AR and ER. Moreover, overexpression of Myc-MEP50 enhanced cell transforming activities of 293T cells which are known lack of expression of AR and ER. Mechanistic analyses showed that MEP50 controlled G2 progression, upregulated cyclin-dependent kinase 1(CDK1)/cyclin B1, and activated the survival cascade Phosphoinositide 3-kinase (PI3K)/AKT. MEP50 promoted cell migration, and activated the cell migration pathways such as Ras-related C3 botulinum toxin substrate 1 (Rac1)/vasodilator-stimulated phosphoprotein (VASP), and forkhead box protein A2 (FOXA2)/slug/cadherin cascades. Further analyses revealed that MEP50 activated the survival factor PI3K through PRMT5-catalyzed dimethylation of PI3K. Collectively, it is concluded that MEP50 can transform cells independent of AR and ER, and PRMT5 has partial contribution to that process.",
keywords = "AKT, Androgen, Estrogen, MEP50, PI3K, PRMT5",
author = "Wei, {Tong You Wade} and Hsia, {Jiun Yi} and Chiu, {Shao Chih} and Su, {Li Jen} and Juan, {Chi Chang} and Lee, {Yuan Chii Gladys} and Chen, {Jo Mei Maureen} and Chou, {Hsiang Yun} and Huang, {Jiao Ying} and Huang, {Hiang Ming} and Yu, {Chang Tze Ricky}",
year = "2014",
month = "9",
day = "1",
doi = "10.1016/j.cellsig.2014.09.014",
language = "English",
volume = "26",
pages = "2940--2950",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis

AU - Wei, Tong You Wade

AU - Hsia, Jiun Yi

AU - Chiu, Shao Chih

AU - Su, Li Jen

AU - Juan, Chi Chang

AU - Lee, Yuan Chii Gladys

AU - Chen, Jo Mei Maureen

AU - Chou, Hsiang Yun

AU - Huang, Jiao Ying

AU - Huang, Hiang Ming

AU - Yu, Chang Tze Ricky

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Methylosome protein 50 (MEP50) is a component of methylosome where MEP50 binds protein substrates and activates the oncogenic protein arginine methyl transferase 5 (PRMT5). MEP50 is also a coactivator for androgen receptor (AR) and estrogen receptor (ER), and transforms cells in the presence of androgen or estrogen. To extend the understanding of how MEP50 transforms cells, we investigated whether MEP50 could transform cells independent of AR and ER, and clarified whether PRMT5 could contribute to the MEP50-caused tumor formation. Microarray and Western blot analyses revealed the association of MEP50 with many human cancers including lung cancer. Knockdown of MEP50 retarded cell growth and migration in selected lung cancer cell lines, which expressed very low level of AR and ER and were insensitive to inhibitors of AR and ER. Moreover, overexpression of Myc-MEP50 enhanced cell transforming activities of 293T cells which are known lack of expression of AR and ER. Mechanistic analyses showed that MEP50 controlled G2 progression, upregulated cyclin-dependent kinase 1(CDK1)/cyclin B1, and activated the survival cascade Phosphoinositide 3-kinase (PI3K)/AKT. MEP50 promoted cell migration, and activated the cell migration pathways such as Ras-related C3 botulinum toxin substrate 1 (Rac1)/vasodilator-stimulated phosphoprotein (VASP), and forkhead box protein A2 (FOXA2)/slug/cadherin cascades. Further analyses revealed that MEP50 activated the survival factor PI3K through PRMT5-catalyzed dimethylation of PI3K. Collectively, it is concluded that MEP50 can transform cells independent of AR and ER, and PRMT5 has partial contribution to that process.

AB - Methylosome protein 50 (MEP50) is a component of methylosome where MEP50 binds protein substrates and activates the oncogenic protein arginine methyl transferase 5 (PRMT5). MEP50 is also a coactivator for androgen receptor (AR) and estrogen receptor (ER), and transforms cells in the presence of androgen or estrogen. To extend the understanding of how MEP50 transforms cells, we investigated whether MEP50 could transform cells independent of AR and ER, and clarified whether PRMT5 could contribute to the MEP50-caused tumor formation. Microarray and Western blot analyses revealed the association of MEP50 with many human cancers including lung cancer. Knockdown of MEP50 retarded cell growth and migration in selected lung cancer cell lines, which expressed very low level of AR and ER and were insensitive to inhibitors of AR and ER. Moreover, overexpression of Myc-MEP50 enhanced cell transforming activities of 293T cells which are known lack of expression of AR and ER. Mechanistic analyses showed that MEP50 controlled G2 progression, upregulated cyclin-dependent kinase 1(CDK1)/cyclin B1, and activated the survival cascade Phosphoinositide 3-kinase (PI3K)/AKT. MEP50 promoted cell migration, and activated the cell migration pathways such as Ras-related C3 botulinum toxin substrate 1 (Rac1)/vasodilator-stimulated phosphoprotein (VASP), and forkhead box protein A2 (FOXA2)/slug/cadherin cascades. Further analyses revealed that MEP50 activated the survival factor PI3K through PRMT5-catalyzed dimethylation of PI3K. Collectively, it is concluded that MEP50 can transform cells independent of AR and ER, and PRMT5 has partial contribution to that process.

KW - AKT

KW - Androgen

KW - Estrogen

KW - MEP50

KW - PI3K

KW - PRMT5

UR - http://www.scopus.com/inward/record.url?scp=84907731998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907731998&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2014.09.014

DO - 10.1016/j.cellsig.2014.09.014

M3 - Article

C2 - 25277535

AN - SCOPUS:84907731998

VL - 26

SP - 2940

EP - 2950

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 12

ER -